Zaira Rehman

Nov 15, 2024 | endocrine-abstracts.org | Christopher Davies |Emily H. Freeman |Zaira Rehman |Alexander B. Boyd

Background: Pancreatic Neuroendocrine tumours (panNETs) are usually sporadic and non-functioning, but occasionally associated with germ-line mutations causing multiple hereditary endocrinopathies. Small, non-functional lesions may be managed conservatively. For panNETs larger than 2 cm the mainstay of treatment is surgery (2). However, postoperative complications are common and can significantly impact patients’ quality of life.

Nov 15, 2024 | endocrine-abstracts.org | Zaira Rehman |Emily H. Freeman |Chris Davies |Alex Boyd

UKINETS2024 22nd Annual Meeting of the UK and Ireland Neuroendocrine Tumour Society 2024 Poster Presentations (33 abstracts) Retrospective study evaluating factors influencing cancer recurrence following surgical resection of pancreatic neuroendocrine tumours (PanNETs)